MDC — Mediclinic International Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareBalancedLarge Cap
- £3.69bn
- £6.12bn
- £3.23bn
Annual cashflow statement for Mediclinic International, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -479 | -137 | -275 | 104 | 211 |
| Depreciation | |||||
| Non-Cash Items | 853 | 484 | 619 | 123 | 113 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -197 | -171 | -105 | -209 | 2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 345 | 344 | 456 | 235 | 554 |
| Other Investing Cash Flow Items | -319 | -298 | -182 | -137 | -189 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -319 | -298 | -182 | -137 | -189 |
| Financing Cash Flow Items | -26 | -13 | -17 | -10 | -13 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -108 | -34 | -207 | -130 | -149 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -100 | 4 | 64 | -35 | 240 |